- Home
- SEER vs RENB Comparison
SEER vs RENB Comparison
Compare SEER & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- RENB
- Stock Information
- Founded
- SEER 2017
- RENB 2011
- Country
- SEER United States
- RENB United States
- Employees
- SEER N/A
- RENB N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- SEER Health Care
- RENB Health Care
- Exchange
- SEER Nasdaq
- RENB Nasdaq
- Market Cap
- SEER 124.9M
- RENB 121.3M
- IPO Year
- SEER 2020
- RENB N/A
- Fundamental
- Price
- SEER $1.97
- RENB $0.35
- Analyst Decision
- SEER Hold
- RENB
- Analyst Count
- SEER 1
- RENB 0
- Target Price
- SEER $3.00
- RENB N/A
- AVG Volume (30 Days)
- SEER 271.4K
- RENB 855.6K
- Earning Date
- SEER 05-07-2025
- RENB 05-14-2025
- Dividend Yield
- SEER N/A
- RENB N/A
- EPS Growth
- SEER N/A
- RENB N/A
- EPS
- SEER N/A
- RENB N/A
- Revenue
- SEER $14,170,000.00
- RENB N/A
- Revenue This Year
- SEER $23.54
- RENB N/A
- Revenue Next Year
- SEER $42.98
- RENB N/A
- P/E Ratio
- SEER N/A
- RENB N/A
- Revenue Growth
- SEER N/A
- RENB N/A
- 52 Week Low
- SEER $1.56
- RENB $0.32
- 52 Week High
- SEER $2.63
- RENB $2.70
- Technical
- Relative Strength Index (RSI)
- SEER 52.65
- RENB 29.29
- Support Level
- SEER $1.97
- RENB $0.35
- Resistance Level
- SEER $2.15
- RENB $0.39
- Average True Range (ATR)
- SEER 0.11
- RENB 0.07
- MACD
- SEER 0.04
- RENB -0.00
- Stochastic Oscillator
- SEER 66.04
- RENB 11.00
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.